文献速递妇科生殖医学

早期宫颈癌保留生育功能手术的系统综述

Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature.
PubMed 文献 · J Minim Invasive Gynecol · 2020-10-24

该系统综述纳入53项研究,评估早期宫颈癌患者接受保留生育功能手术后的肿瘤学和生殖结局。结果表明,经腹、经阴道或微创根治性宫颈切除术的肿瘤学结局相当,生殖结局以经阴道根治性宫颈切除术更优;锥切或单纯宫颈切除术的数据较弱但支持相似肿瘤学结局且生殖并发症更少。新辅助化疗在此场景需进一步研究。

要点

  • 经阴道根治性宫颈切除术的妊娠率49.4%、活产率65.0%,生殖结局优于其他根治性术式。
  • 根治性宫颈切除术(经腹、经阴道、微创)的复发率约4%,癌死亡率约1%–2%。
  • 锥切或单纯宫颈切除术的肿瘤学结局与根治性宫颈切除术相似,生殖并发症更少。

核心结论

  • 在严格选择的早期宫颈癌患者中,经阴道、经腹或微创根治性宫颈切除术的肿瘤学结局相当,生殖结局以经阴道根治性宫颈切除术更优。
  • 锥切或单纯宫颈切除术的数据稳健性较低,但支持与根治性宫颈切除术相似的肿瘤学结局且生殖并发症更少。
  • 新辅助化疗在保留生育功能手术场景中需进一步研究方可常规实践。

研究设计与样本

  • 系统综述,检索Ovid MEDLINE、Ovid EMBASE和Cochrane CENTRAL从1980年至今的文献。
  • 共筛选2415项研究,最终纳入53项报告早期宫颈癌(FIGO 2009 IA期伴淋巴血管间隙浸润、IB期或IIA期)传统组织学类型接受保留生育功能手术且中位随访12个月复发情况的研究。

主要发现

  • 经阴道根治性宫颈切除术:复发率4%、癌死亡率1.7%、妊娠率49.4%、活产率65.0%。
  • 经腹根治性宫颈切除术:复发率3.9%、癌死亡率1.4%、妊娠率43.2%、活产率44.0%。
  • 微创根治性宫颈切除术:复发率4.2%、癌死亡率0.7%、妊娠率36.2%、活产率57.1%。
  • 锥切或单纯宫颈切除术:复发率4.2%、癌死亡率0.8%、妊娠率55.1%、活产率71.9%。
  • 新辅助化疗:复发率7.5%、癌死亡率2.0%。

临床怎么用

  • 对严格选择的早期宫颈癌患者,可考虑经阴道、经腹或微创根治性宫颈切除术保留生育功能,其中经阴道术式生殖结局更优。
  • 锥切或单纯宫颈切除术可作为非根治性保留生育功能选项,但需认识其数据稳健性较低。
  • 新辅助化疗联合保留生育功能手术不应作为常规实践,需进一步研究。

局限性

  • 锥切或单纯宫颈切除术及新辅助化疗的数据稳健性较低,需更多研究验证。
  • 各术式合并率基于报告该术式结局的所有纳入研究计算,可能存在异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This systematic review aimed to evaluate oncologic and reproductive outcomes after fertility-sparing surgery (FSS) for early-stage cervical cancer (early CC). DATA SOURCES: Ovid MEDLINE, Ovid EMBASE, and Cochrane CENTRAL were searched from 1980 to the present using Medical Subject Headings terms; other controlled vocabulary terms; and keywords related to fertility, cervical cancer, and surgical techniques. METHODS OF STUDY SELECTION: A total of 2415 studies were screened, with 53 studies included. Studies reporting recurrences with a median follow-up of 12 months in early CC (International Federation of Gynecology and Obstetrics 2009 stages IA with lymphovascular space invasion, IB, or IIA) of traditional histologic type undergoing FSS were included. TABULATION, INTEGRATION, AND RESULTS: The studies were grouped by intervention, including vaginal radical trachelectomy (VRT), abdominal radical trachelectomy (ART), minimally invasive radical trachelectomy (MIS-RT), and conization or simple trachelectomy (ST), and studies involving neoadjuvant chemotherapy (NACT). Combined rates of recurrence (RR), cancer death (CDR), pregnancy (PR), and live birth (LBR) were calculated per procedure on the basis of all included studies that reported outcomes on that procedure. The results were as follows: VRT: RR 4%, CDR 1.7%, PR 49.4%, and LBR 65.0% ART: RR 3.9%, CDR 1.4%, PR 43.2%, and LBR 44.0% MIS-RT: RR 4.2%, CDR 0.7%, PR 36.2%, and LBR 57.1% Cone or ST: RR 4.2%, CDR 0.8%, PR 55.1%, and LBR 71.9% NACT: RR 7.5% and CDR 2.0% CONCLUSION: FSS of early CC with VRT, ART, or MIS-RT have comparable oncologic outcomes in carefully selected patients, with reproductive outcomes favoring VRT. Data on nonradical FSS with cone or ST are less robust but support similar oncologic outcomes to radical trachelectomy with fewer reproductive complications. NACT in this setting requires more investigation before routine implementation into practice.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Kuznicki ML, Chambers LM, Morton M, et al. Fertility-Sparing Surgery for Early-Stage Cervical Cancer: A Systematic Review of the Literature. J Minim Invasive Gynecol. 2020. PMID: 33223017. doi:10.1016/j.jmig.2020.10.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。